EP1013
EP1013 (F1013) is a broad-spectrum caspase selective inhibitor, used in the research of type 1 diabetes[1].
Product Specifications
CAS Number
[223568-55-6]
Product Name Alternative
F1013
UNSPSC
12352005
Target
Caspase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/EP1013.html
Concentration
10mM
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C[C@H](NC([C@H](C(C)C)NC(OCC1=CC=CC=C1)=O)=O)C(CF)=O
Molecular Formula
C18H23FN2O6
Molecular Weight
382.38
References & Citations
[1]Emamaullee JA, et al. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes. 2008 Jun;57 (6) :1556-66.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
214127-01 20 µL
VEGFR1 (Vascular Endothelial Growth Factor Receptor 1, FLT, FLT-1, VEGFR1, VEGFR-1) discontinued
Ask
View Details 
214127-02 100 µL
VEGFR1 (Vascular Endothelial Growth Factor Receptor 1, FLT, FLT-1, VEGFR1, VEGFR-1) discontinued
Ask
View Details 